| miR-221/222与肿瘤发生发展关系的研究进展 |
| |
| 引用本文： | 杨萌萌,陈红跃.miR-221/222与肿瘤发生发展关系的研究进展[J].中国临床新医学,2020,13(3):313-317. |
| |
| 作者姓名： | 杨萌萌 陈红跃 |
| |
| 作者单位： | 450002 郑州，河南中医药大学（杨萌萌，武红园）；450002 郑州，河南省中医院甲状腺乳腺科（陈红跃） |
| |
| 基金项目： | 河南省中医药科学研究专项课题（编号：2016ZY2063） |
| |
| 摘 要： | 微小RNA-221/222(miR-221/222)是一类与肿瘤发生密切相关的微小RNA,异常表达存在于机体多系统、多步骤、多位点肿瘤的分化发展进程中。miR-221/222通过靶向不同靶基因的信号转导途径发挥着抑癌基因或促癌基因的作用,有望成为恶性肿瘤的生物学标志物和新型治疗靶点。该文就miR-221/222与肿瘤发生发展关系的研究进展作一综述。
|
| 关 键 词： | 微小RNA-221/222 肿瘤 靶基因 |
| 收稿时间： | 2019/6/14 0:00:00 |
Research progress on the relationship between miR-221/222 and tumorigenesis and development |
| |
| YANG Meng-meng,CHEN Hong-yue,WU Hong-yuan.Research progress on the relationship between miR-221/222 and tumorigenesis and development[J].Chinese Journal of New Clinical Medicine,2020,13(3):313-317. |
| |
| Authors: | YANG Meng-meng CHEN Hong-yue WU Hong-yuan |
| |
| Institution: | Henan University of Chinese Medicine, Zhengzhou 450002, China |
| |
| Abstract: | Micro ribonucleic acid-221/222(miR-221/222)is a kind of microRNAs closely related to tumorigenesis.Abnormal expression of miR-221/222 exists in the process of differentiation and development of multi-system,multi-step and multi-site tumors.MicroRNA-221/222 plays the role of tumor suppressor or oncogene through signal transduction pathway targeting different target genes,and is expected to become a biomarker and a novel therapeutic target for malignant tumors.In this paper,we review the research progress on the relationship between miR-221/222 and tumorigenesis and development. |
| |
| Keywords: | Micro ribonucleic acid-221/222(miR-221/222) Tumors Target gene |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《中国临床新医学》浏览原始摘要信息 |
| 点击此处可从《中国临床新医学》下载免费的PDF全文 |
